首页> Molecular therapy. Oncology> TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs.

TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs.

导出 LinkOut

翻译打印收藏纠错

第一作者： Qingyu,Liao

第一单位： Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.

作者： Qingyu,Liao ^[1] ; Ruiming,Zhang ^[1] ; Zuli,Ou ^[1] ; Yan,Ye ^[1] ; Qian,Zeng ^[1] ; Yange,Wang ^[1] ; Anqi,Wang ^[2] ; Tingmei,Chen ^[1] ; Chengsen,Chai ^[1] ; Bianqin,Guo ^[3]

作者单位： Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China. ^[1] CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing100190, China. ^[2] Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.;Department of Clinical Laboratory, Chongqing University Cancer Hospital, Chongqing 40030, China. ^[3]

关键词 CTCs EMT MT: Regular Issue TNBC TROP2 biomarker circulating tumor cells epithelial-mesenchymal transition triple-negative breast cancer trophoblast cell surface antigen 2

DOI 10.1016/j.omton.2024.200762

PMID 38596285

发布时间 2024-04-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Molecular therapy. Oncology

2024年32卷1期

200762页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Molecular therapy. Oncology

2024年32卷1期

200762页

检索历史清除

TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs.

Molecular therapy. Oncology

相似文献

同项目论文

Molecular therapy. Oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs.

Molecular therapy. Oncology

相似文献

同项目论文

Molecular therapy. Oncology

相关期刊

检索历史清除